共 48 条
- [31] Bifidobacterium animalis subsp. lactis LKM512 reduces levels of intestinal trimethylamine produced by intestinal microbiota in healthy volunteers: A double-blind, placebo-controlled study (vol 36, pg 94, 2017)JOURNAL OF FUNCTIONAL FOODS, 2018, 42Matsumoto, MitsuharuKitada, YusukeShimomura, YumiNaito, Yuji
- [32] Influence of synbiotic containing Lactobacillus acidophilus La5, Bifidobacterium lactis Bb 12, Streptococcus thermophilus, Lactobacillus bulgaricus and oligofructose on gut barrier function and sepsis in critically ill patients:: A randomised controlled trialCLINICAL NUTRITION, 2004, 23 (04) : 467 - 475Jain, PKMcNaught, CEAnderson, ADGMacFie, JMitchell, CJ
- [33] Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies (vol 401, pg 1159, 2023)LANCET, 2023, 401 (1038): : 1000 - 1000Sandborn, W. J.Vermeire, S.Peyrin-Biroulet, L.
- [35] A RANDOMISED PLACEBO-CONTROLLED DOUBLE-BLIND STUDY OF OCTASA® 4.8 G/DAY (800 MG TABLETS 5-ASA) FOR THE INDUCTION OF ENDOSCOPIC REMISSION IN PATIENTS WITH ACTIVE ULCERATIVE COLITISGUT, 2012, 61 : A170 - A170Feagan, B. G.Mittmann, U.Gilgen, D.Wong, C. J.Mikhailova, E.Levchenko, O.Marakhouski, Y.
- [36] Anti-MAdCAM antibody (PF-00547659) for ulcerative colitis (TURANDOT): a phase 2, randomised, double-blind, placebo-controlled trial (vol 390, pg 135, 2017)LANCET, 2018, 392 (10165): : 2696 - 2696Vermeire, S.Sandborn, W. J.Danese, S.
- [37] Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial (vol 5, pg 597, 2017)LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (11): : E7 - E7Petrie, J. R.Chaturvedi, N.Ford, I
- [38] Vorapaxar for HIV-associated inflammation and coagulopathy (ADVICE): a randomised, double-blind, placebo-controlled trial (vol 5, pg e553, 2018) LANCET HIV, 2019, 6 (12): : E815 - E815
- [39] Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial (vol 5, pg 597, 2017)LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (08): : E5 - E5Petrie, J. R.Chaturvedi, N.Ford, I
- [40] The benefit of minocyline on negative symptoms of schizophrenia in patients with recent-onset psychosis (BeneMin): a randomised, double-blind, placebo-controlled trial (vol 5, pg 885, 2018)LANCET PSYCHIATRY, 2018, 5 (12): : E28 - E28Deakin, B.Suckling, J.Barnes, T. R. E.